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Retroviral genetic rearrangements can result from reverse transcriptase template switching. Most published data suggest
that errors such as base misincorporation occur at similar frequencies for HIV-1 and for simple retroviruses such as spleen
necrosis virus (SNV) and murine leukemia virus (MuLV). However, previous reports have suggested that template switch-
mediated recombination is much more frequent for HIV-1 than for simple retroviruses. In this report, direct repeat deletion
vectors similar to those previously used for measuring template switching events for SNV and MuLV were developed for
HIV-1. Forward mutation rates and the frequency of template switching during a single cycle of HIV-1 replication were
determined. The frequency of HIV-1-mediated repeat deletion was measured for three separate internal repeats in lacZ and
was compared to rates observed with identical repeats for MuLV. The results indicated that the error rate and the frequency
of repeat deletion of HIV-1 were similar to those of MuLV. © 2001 Academic Press
Key Words: genetic recombination; template switching; HIV-1 replication.
PINTRODUCTION
Cumulative evidence suggests that, similar to other
members of the Retroviridae family, HIV-1 reverse tran-
scription is prone to both nucleotide misincorporation
(mutations) and genetic recombination. Although the
steady state composition of retroviral populations is de-
termined more by selection than by error frequency, the
high rate of errors associated with HIV-1 replication is an
important factor in HIV-1 disease because it provides the
genetic diversity from which variants can be selected.
Many studies with purified enzymes have demon-
strated that HIV-1 reverse transcriptase base misincor-
poration rates are high and that this kind of mutation also
arises frequently during viral replication (Preston and
Dougherty, 1996). Although the rate of misincorporation
during HIV-1 replication is much higher than that of the
cellular replication machinery, it is about 20-fold lower
than values obtained for purified HIV-1 RT (Mansky and
Temin, 1995). Most studies suggest that misincorpora-
tion rates during lentivirus replication are similar to or
somewhat higher than those for simple retroviruses
(Pathak and Temin, 1990a,b; Mansky, 2000; Mansky and
Temin, 1994). For example, in a study that used lacZa as
a reporter, a forward mutation rate of 3.4 3 1025 muta-
tions per base per HIV-1 replication cycle was observed
(Mansky and Temin, 1995). This is twofold higher than
1 To whom correspondence and reprint requests should be ad-
dressed at 1150 W. Medical Center Drive, Room 5641, Ann Arbor, MI
8109-0620. Fax: 734-764-3562. E-mail: ateles@umich.edu.
475values obtained during spleen necrosis virus (SNV) rep-
lication (Pathak and Temin, 1990a,b).
Some studies suggest that genetic recombination may
be a more significant source of retroviral phenotypic
variation than base misincorporation, especially for
HIV-1 (Mansky, 2000; Parthasarathi et al., 1995). Retrovi-
ral genetic recombination results from template switch-
ing between copackaged RNAs (Hu and Temin, 1990;
Hunter, 1978; Stuhlmann and Berg, 1992). One approach
to the study of retroviral recombination is to introduce
genetic markers into two different retroviral vectors and
to examine the progeny proviral DNA from virions con-
taining these coexpressed RNAs (Yu et al., 1997). By this
approach, the recombination frequency of HIV-1 was
determined to be two to three recombination events per
genome per replication cycle (Jetzt et al., 2000). This is
roughly 10-fold higher than rates determined using sim-
ilar approaches for SNV (Hu and Temin, 1990) and mu-
rine leukemia virus (MuLV) (Anderson et al., 1998).
Another approach for studying retroviral recombina-
tion-related properties is to measure direct repeat dele-
tion. Repeated sequences are deleted frequently during
retroviral replication (Rhode et al., 1987), and deletion
rates have been measured previously for SNV and MuLV
(Delviks et al., 1997; Delviks and Pathak, 1999; Julias et
al., 1995; Pathak and Temin, 1990a; Pfeiffer et al., 1999).
Though not an absolute rule, MuLV and SNV deletion
frequencies correlate roughly with repeat length (Delviks
et al., 1997; Delviks and Pathak, 1999; Julias et al., 1995;
feiffer et al., 1999; Zhang and Temin, 1994). Repeat
eletion rates have not been reported for HIV-1.
Here, we established a system for analyzing HIV-1
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476 AN AND TELESNITSKYmutation and direct repeat deletion rates during single
cycles of viral replication. In contrast to reported large
differences in intermolecular recombination frequencies
between HIV-1 and certain simple retroviruses, we found
that mutation rates and direct repeat deletion rates for
HIV-1 and MuLV were very similar.
RESULTS
Vector and cell system to study HIV-1 direct repeat
deletion during a single cycle of replication
An assay was established to examine direct repeat
deletion rates during single cycles of HIV-1 replication. A
single cycle is defined as starting with transcription and
virus production in the producer cell and then continuing
through infection, reverse transcription, and proviral DNA
integration into the target cell. In our system, replication
was limited to a single cycle because vector virus was
pseudotyped with ecotropic MuLV envelope that was
constitutively expressed by the producer cells (Pfeiffer et
al., 1999), and 293-derived cells that express ecotropic
receptor were used as the human target cell line (mA-
TRC1/293 cells) (Malhotra et al., 1996). Vector virus gen-
erated in the producer cells could not infect producer
cells because they lack ecotropic receptor, and no infec-
tious virus was produced by infected target cells since
the target cells were devoid of helper function. The titer
of vector virus was typically 104 transducing units per
illiliter, which is about one order of magnitude lower
han those reported for similar HIV-1 vectors
seudotyped with amphotropic envelope or VSV-G (Nal-
ini et al., 1996b).
For the assays employed here, the lentivirus helper
onstruct, pCMVDR8.2 (Naldini et al., 1996a), provided all
IV-1 proteins except envelope in trans for HIV-1-based
ransducing vectors (Fig. 1A). The wild-type transducing
ector, pHIVlac, was a derivative of pHR9CMVlacZ (Nal-
ini et al., 1996b), engineered to include a puromycin
esistance gene driven by the SV40 early promoter. pHIV-
aac117, pHIVlaac284, and pHIVlaac971 differed from
HIVlac in that each contained a 117-, 284-, or 971-bp
irect repeat within lacZ, respectively.
To produce viral particles, individual transducing vec-
or and helper constructs were cotransfected into pro-
ucer cells, and virus was harvested and used to infect
usceptible human cells (Malhotra et al., 1996) (Fig. 1B).
fter 2 weeks of selection, puromycin-resistant colonies
ere X-gal stained. If precise repeat deletion occurred
uring reverse transcription, cells should stain blue; if
he repeats were maintained, colonies would not stain.
eletion rates were calculated as ratios of blue colonies
o the total number of colonies. For each transducing
ector, virus was prepared from three separate cotrans-
ections, and two independent infections were performed
n triplicate on each virus stock to assess deletion rates
uring single replication cycles.acZ inactivation during HIV-1 replication
Due to HIV-1’s high mutation rate, the reconstituted
acZ gene in some proviral DNAs may be inactivated
ven if precise deletion takes place. To determine the
nactivation rate of lacZ in our system, pHIVlac (which
ontains uninterrupted lacZ) was cotransfected into pro-
ucer cells with pCMVDR8.2, target cells were infected,
nd puromycin-resistant colonies were counted after X-
al staining. The inactivation rate of lacZ was calculated
s the ratio of white colonies to total colonies (Table 1).
he results suggested that lacZ was inactivated at a rate
f 6.4% for HIV-1 during single replication cycles, which
s comparable to frequencies measured for MuLV (Julias
t al., 1997; Julias and Pathak, 1998; Pfeiffer et al., 1999).
he roughly 1.6-fold difference between our measure-
ent and previously reported HIV-1 error frequencies
Mansky and Temin, 1995) may not be significant or it
ay reflect the different approaches used.
eletion rates for different length direct repeats
To determine repeat deletion values for HIV-1, the
otransfection, infection, selection, and staining protocol
utlined above was repeated using pHIVlaac117, pHIV-
aac284, and pHIVlaac971 as transducing vectors and
CMVDR8.2 as helper (Table 2). The deletion rates mea-
ured by blue/total colony ratios for 117, 284, and 971
ase direct repeats were 6.4, 18.6, and 81.4%, respec-
ively. Factoring in the 6.4% lacZ inactivation rate deter-
ined above, calculated deletion frequencies were 6.8,
9.9, and 87%, respectively.
mATRC1/293 cells were also infected with MuLV-
ased vectors that contained the same lacZ repeats to
ompare deletion frequencies for the MuLV and HIV-1
eplication machinery. The values determined here for
uLV infection of mATRC1/293 cells are shown in Table
. In our previous work, murine NIH-3T3 cells were
nfected with these same vectors, and MuLV repeat de-
etion values ranged from 4.8 3 1022 per base per cycle
of replication (5.6% deletion of a 117 base repeat) to
10.6 3 1022 per base per cycle (30% deletion of a 284
base repeat), with an intermediate value of 6.8 3 1022
per base per cycle (66% deletion of a 971 base repeat) for
the longest repeat studied (Pfeiffer et al., 1999). As indi-
cated in Fig. 2, the rates of repeat deletion for MuLV
vectors reverse-transcribed in human mATRC1/293 cells
were very similar to the MuLV deletion frequencies pre-
viously determined for products generated in murine
NIH-3T3 cells.
Effect of HU and AZT treatment on lacZ inactivation
and repeat deletion rates
HU inhibits cellular ribonucleotide reductase and can
induce dNTP pool imbalance. HU treatment has been
shown to modestly increase direct repeat deletion rates
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477HIV-1 TEMPLATE SWITCHINGfor MuLV and lacZ inactivation rates in SNV and MuLV
(Julias and Pathak, 1998; Pfeiffer et al., 1999; Svarovskaia
t al., 2000). AZT, the RT nucleoside inhibitor widely used
n clinical therapy of HIV disease, also affects mutation
FIG. 1. HIV-1 vector system and protocol for direct repeat deleti
pHIVlaac117, pHIVlaac284, and pHIVlaac971) and helper function vec
indicated by shaded boxes. (B) To generate vector virus, individual tra
al., 1999). mATRC1/293 cells (Malhotra et al., 1996) were infected with
number of blue and white colonies were counted and used to calculaates (Julias et al., 1997; Mansky and Bernard, 2000).
To address effects of HU and AZT treatment on lacZ
t
inactivation in our system, mATRC1/293 cells were in-
ected with HIVlac vector virus and incubated in culture
edia supplemented with 0.2 mM HU or 1.0 mM AZT,
ith untreated cells used as a control (Table 1). The HU
ay. (A) Schematic drawings of HIV-1 transducing vectors (pHIVlac,
MVDR8.2; Naldini et al., 1996a). The locations of direct repeats are
g vector was cotransfected with pCMVDR8.2 into ET cells (Pfeiffer et
s, selected with puromycin, and subsequently stained with X-gal. The
ates of direct repeat deletion.on ass
tor (pC
nsducinreatment resulted in 8.5% lacZ inactivation, or a 1.3-fold
ncrease compared to untreated cells. This slight in-
p ee dish
er of w
p
478 AN AND TELESNITSKYcrease for HIV-1 is lower than the reported 1.8- to 2.7-fold
increases for MuLV and a 2.1-fold increase reported for
SNV undergoing reverse transcription in HU-treated cells
(Julias and Pathak, 1998; Pfeiffer et al., 1999). When target
cells were infected in the presence of AZT, the lacZ
inactivation rate was 7.3%, or 1.1-fold higher than in un-
treated cells. This magnitude of effect is lower than those
reported in other studies, where treatment with a similar
concentration of AZT increased the MuLV lacZ inactiva-
tion rate threefold (Julias et al., 1997). Even lower con-
centrations of AZT were found to increase lacZ inactiva-
tion for SNV by 7- to 10-fold (Julias et al., 1997) and to
increase forward mutation of lacZa 7-fold for HIV-1 (Man-
sky and Bernard, 2000). The cause of the differences in
magnitudes of AZT effects between values determined
here and those reported previously was not determined,
but differences may reflect cell-line specific differences
in AZT processing or investigator-specific differences in
methodology.
T
Effect of HU or AZT Treatmen
Experiment
No.a
No treatment
No. of blue
colonies
No. of white
colonies
Inactivation
rate (%)b
No. of blue
colonies
1.1 245 27 9.9 180
1.2 3313 240 6.8 2207
2.1 726 36 4.7 194
2.2 3034 218 6.7 1621
3.1 1637 85 4.9 682
3.2 3240 173 5.1 1216
Avg 6.4
SD 2.0
a The first number indicates separate cotransfections from which vi
erformed in triplicate. Data provided are sums of values from the thr
b The lacZ inactivation rate was calculated as the ratio of the numb
T
Deletion Rates of Direct Re
Experiment
No.a
117-base repeat
No. of blue
colonies
No. of white
colonies
Deletion
rate (%)b
No. of blu
colonies
1.1 99 1437 6.4 254
1.2 500 5546 8.3 228
2.1 289 3757 7.1 339
2.2 185 2324 7.4 840
3.1 61 1348 4.3 317
3.2 30 620 4.6 106
Avg 6.4
SD 1.6
a The first number indicates separate cotransfections from which vi
erformed in triplicate. Data provided are sums of values from the three dish
b The deletion rate was calculated as the ratio of the number of blue colonTo study the effect of HU and AZT treatment on HIV-1
direct repeat deletion, target cells were infected with
HIVlaac117 virus and incubated in media containing 0.2
mM HU or 1.0 mM AZT. Deletion rates were determined
as above (Table 4). When treated with 0.2 mM HU, the
deletion rate increased to 11.4%. This 1.8-fold increase
upon HU treatment is similar in magnitude to that which
we observed for the identical lacZ repeat in MuLV vec-
tors (Pfeiffer et al., 1999) and is very similar to the 1.7-fold
increase observed by another group that subsequently
measured HU effects on MuLV repeat deletion (Svarovs-
kaia et al., 2000). When treated with 1.0 mM AZT, the
deletion rate increased to 10.3%, a 1.6-fold increase over
the deletion rate in untreated target cells.
DISCUSSION
We established a system for examining HIV-1 direct
repeat deletion rates during single cycles of viral repli-
Z Inactivation Rates of HIV-1
treatment AZT treatment
. of white
olonies
Inactivation
rate (%)b
No. of blue
colonies
No. of white
colonies
Inactivation
rate (%)b
19 9.5 196 17 8.0
258 10.5 2104 213 9.2
15 7.2 256 20 7.2
144 8.2 602 39 6.1
64 8.6 628 42 6.3
87 6.7 596 45 7.0
8.5 7.3
1.4 1.2
ere produced, and the second number indicates separate infections
es.
hite colonies to the total number of colonies.
f Different Length of HIV-1
base repeat 971-base repeat
o. of white
colonies
Deletion
rate (%)b
No. of blue
colonies
No. of white
colonies
Deletion
rate (%)b
1005 20.2 2429 578 80.8
1119 16.9 2192 547 80.0
1401 19.5 2125 462 82.1
3419 19.7 1236 236 84.0
1405 18.4 637 134 82.6
514 17.1 1914 522 78.6
18.6 81.4
1.4 1.9
ere produced, and the second number indicates separate infectionsABLE 1
t on lac
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No
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479HIV-1 TEMPLATE SWITCHINGcation. Direct repeat deletion, measured by the fre-
quency of marker gene reconstitution, has been used as
a measure of homologous recombination frequency dur-
ing both cellular and viral DNA synthesis (Bierne et al.,
1997; Delviks et al., 1997; Delviks and Pathak, 1999; Julias
t al., 1995; Pfeiffer et al., 2000; Pfeiffer et al., 1999;
Svarovskaia et al., 2000; Xu and Boeke, 1987; Zhang and
Sapp, 1999). An important feature of this new HIV-1-
based assay was that the lacZ expression unit and the
repeats within lacZ used to measure deletion frequen-
cies were identical to those previously used to assess
MuLV template switching (Pfeiffer et al., 1999). This was
important for allowing a comparison of deletion frequen-
cies by MuLV and HIV-1 because reverse transcriptase
errors do not occur at uniform frequencies and are highly
context-dependent (Anderson et al., 1998; Ricchetti and
Buc, 1990; Wooley et al., 1998). For example, sequences
that potentially form secondary structures have been
T
lacZ Inactivation Rates and Deletion Rates of Direct R
Experiment
No.a
Wild type 117-base rep
No. of
blue
colonies
No. of
white
colonies
Inactivation
rate (%)b
No. of
blue
colonies
No. of
white
colonies
1 3639 337 8.5 89 2947
2 1908 168 8.1 65 1909
Avg 8.3
SD 0.3
a Each experiment involves independent infection of six dishes. Dat
b The lacZ inactivation rate was calculated as the ratio of the numb
c The deletion rate was calculated as the ratio of the number of blu
FIG. 2. lacZ inactivation and repeat deletion frequencies for HIV-1 and
deletion frequencies are indicated in the main figure. Values for HIV-1 v
(gray bars), and MuLV assayed in NIH-3T3 cells (black bars; from Pfeiffer et
nactivation frequencies.shown to be hot spots for both mutation and recombina-
tion (Jetzt et al., 2000; Jones et al., 1994; Pathak and
Temin, 1992). These and other poorly understood tem-
plate features that affect error frequencies are not
present at uniform frequencies throughout templates.
The system used here eliminated template structure and
sequence context as variables and allowed direct com-
parison of MuLV replication properties in murine cells to
those of HIV-1 in human cells.
Findings reported here demonstrated that direct re-
peat deletion frequencies of MuLV and HIV-1, when both
viruses were tested with identical repeats in the same
human cell type, were very similar. The measured values
agreed well with deletion rates previously determined by
others for MuLV in murine cells and SNV in canine cells
(Delviks et al., 1997; Delviks and Pathak, 1999; Julias et
al., 1995; Pfeiffer et al., 1999; Svarovskaia et al., 2000).
Thus, we conclude that HIV-1 deletes repeats at a fre-
of Different Lengths of MuLV in mATRC1/293 Cells
284-base repeat 971-base repeat
ion
%)c
No. of
blue
colonies
No. of
white
colonies
Deletion
rate (%)c
No. of
blue
colonies
No. of
white
colonies
Deletion
rate (%)c
1215 2303 34.5 928 300 75.6
703 1457 32.5 1100 479 69.7
33.5 72.6
1.4 4.2
ded are sums of values from the six dishes.
hite colonies to the total number of colonies.
ies to the total number of colonies.
Comparison of lacZ inactivation rates is shown in the insert and repeat
assayed in mATRC1/293 cells (white bars), MuLV in mATRC1/293 cellsABLE 3
epeats
eat
Delet
rate (
2.9
3.3
3.1
0.3
a proviMuLV.
ectorsal., 1999). Repeat deletion values were corrected to account for lacZ
p ee dish
er of w
480 AN AND TELESNITSKYquency similar to simple retroviruses such as to MuLV
and SNV. This finding was unexpected because previous
measurements of intermolecular template switching
rates between copackaged RNAs have suggested that
HIV-1 template switching is about 10-fold more frequent
than that of SNV or MuLV (Hu and Temin, 1990; Anderson
et al., 1998; Jetzt et al., 2000).
Possible explanations for this new finding of similar
repeat deletion rates for HIV-1 and MuLV—despite vast
reported recombination differences—range from techni-
cal differences of no biological importance to potentially
significant differences in replication properties. For ex-
ample, whereas HIV-1 intermolecular switching in a sin-
gle-cycle assay occurred two or three times per cycle
(Jetzt et al., 2000), data with replication-competent virus
from a different research group suggests only one cross-
over occurs per replication cycle (St Louis et al., 1998). It
is similarly possible that if another research group using
different approaches addressed simple retrovirus re-
combination rates, they might be revised upward. Thus,
technical differences between labs might erode the re-
ported 10-fold difference between HIV-1 and simple ret-
rovirus recombination frequencies.
Another possibility is that although the highly mosaic
nature of natural HIV-1 recombinants appears consistent
with high recombination frequencies (Quinones-Mateu
and Arts, 1999), these mosaic genomes may have re-
sulted from negative interference, which occurs during
the replication of simple retroviruses (Hu et al., 1997).
Negative interference is the phenomenon in which ret-
roviral genomes that show any evidence of genetic re-
combination tend to display more crossovers than would
be predicted based on calculated average recombina-
tion rates. If previously described HIV-1 recombinants
T
Effect of HU or AZT Treatment on Delet
Experiment
No.a
No treatment
No. of blue
colonies
No. of white
colonies
Deletion
rate (%)b
No. of blu
colonies
1.1 99 1437 6.4 44
1.2 500 5546 8.3 533
2.1 289 3757 7.1 135
2.2 185 2324 7.4 101
3.1 61 1348 4.3 63
3.2 30 620 4.6 20
Avg 6.4
SD 1.6
a The first number indicates separate cotransfections from which vi
erformed in triplicate. Data provided are sums of values from the thr
b The lacZ inactivation rate was calculated as the ratio of the numbare not typical HIV-1 reverse transcription products but
instead products of a rare “recombining population”(Anderson et al., 1998), then HIV-1 and simple retrovirus
recombination rates may be indistinguishable over all.
A third possibility is that direct repeat deletion and
intermolecular recombination may differ mechanistically,
so one cannot be used as a predictor for the other. A
possible precedent for this notion lies in the observation
that direct repeat deletion in Escherichia coli is indepen-
dent of the recombination protein RecA, whereas other
forms of homologous recombination are RecA-depen-
dent (Lovett et al., 1993).
A fourth possibility is that template switching frequen-
cies may be the same for the studied retroviruses but
that their genome organizations may differ, thus leading
to the appearance of differences where none exist. Ret-
roviral recombination is detectable only when it occurs
between genetically distinct templates (Hu et al., 1993).
Although the possibility that RNA copackaging may not
be random has been discussed (Hu et al., 1997), a
general assumption has been that when two similar
retroviral RNAs are coexpressed in single cells, they will
dimerize and thus copackage randomly, and hence num-
bers of “heterozygous” particles can be calculated from
the total amount of each RNA in the population. However,
how RNAs are recruited for packaging is not well under-
stood, and there is some evidence that these processes
may differ among retroviruses (Kaye and Lever, 1999). If
MuLV RNA homodimers were packaged preferentially
but dimerization and copackaging were random for
HIV-1, HIV-1 recombination would appear to be more
frequent than that of MuLV even if template switching
rates were indistinguishable.
MATERIALS AND METHODS
Plasmids and cells
es of 117-Base Direct Repeats of HIV-1
treatment AZT treatment
o. of white
colonies
Deletion
rate (%)b
No. of blue
colonies
No. of white
colonies
Deletion
rate (%)b
360 10.9 42 395 9.6
3188 14.3 185 1708 9.8
1177 10.3 159 1277 11.1
747 11.9 48 330 12.7
526 10.7 50 542 8.4
175 10.3 13 115 10.2
11.4 10.3
1.5 1.5
ere produced, and the second number indicates separate infections
es.
hite colonies to the total number of colonies.ABLE 4
ion Rat
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ruses wThe HIV-1 transducing vector, pHIVlac, was a deriva-
tive of pHR9CMVlacZ (Naldini et al., 1996b), which con-
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481HIV-1 TEMPLATE SWITCHINGtains cis-acting sequences necessary for reverse tran-
cription, packaging, and integration. To construct pHIV-
ac, the MfeI–NheI plasmid backbone of pHR9CMVlacZ
as replaced with an EcoRI–XbaI fragment from pUC18.
hen a 1-kb Asp 718–SalI fragment containing an SV40
arly promoter and a puromycin-resistance gene from an
uLV-based vector (Kulpa et al., 1997) was inserted
ownstream of lacZ. pHIVlaac117, pHIVlaac284, and
HIVlaac971 were constructed by replacing the FspI–
coRI lacZ fragment of pHIVlac with corresponding frag-
ents from MuLV-based vectors, pLaac-117, pLaac-284,
nd pLaac-971 (Pfeiffer et al., 1999). The helper function
lasmid used, pCMVDR8.2 (Naldini et al., 1996a), en-
odes all HIV-1 trans-acting proteins including Vpu but
ot envelope, driven by a CMV immediate early pro-
oter.
ET cells are a 293T derivative that constitutively ex-
resses ecotropic envelope (Pfeiffer et al., 1999). mA-
RC1/293 cells are derived from the human 293 cell line
nd stably express the receptor for ecotropic Env (Mal-
otra et al., 1996). Both of these cell lines and their
erivatives were grown in Dulbecco’s modified Eagle’s
edium (DMEM) supplemented with 10% fetal bovine
erum (Gemini).
ransfection and virus harvesting
HIVlac and HIVlaac vector viruses were generated by
ransiently cotransfecting ET cells with pCMVDR8.2 and
he corresponding transducing vector plasmid by cal-
ium phosphate precipitation (Miller et al., 1993). Virus
as harvested by replacing culture medium 16–24 h after
ransfection and collecting medium 36–48 h posttrans-
ection. Residual cells were removed from the medium
y 4°C low-speed centrifugation for 5 min at 3000 g.
irus was stored at 270°C prior to use. For each HIV-1
ransducing vector, three viral stocks were prepared from
eparate cotransfections.
MuLV vector viruses were produced using the same
pproaches, except that ET cells were cotransfected
ith the MuLV helper construct, pMLVC2, and the MuLV
transducing constructs, pLaac-117, pLaac-284, and
pLaac-971 (Pfeiffer et al., 1999), respectively. Virus stocks
were prepared and stored as described above and used
to infect mATRC1/293 cells as described below for the
HIV-1 based vectors.
Infection and functional assay for LacZ activity
mATRC1/293 cells in 6-cm-diameter dishes were in-
fected 1 h in the presence of 8 mg/ml of hexadimethrine
romide (Polybrene; Sigma). Puromycin (Sigma) selec-
ion, cell fixation, and 5-bromo-4-chloro-b-D-galactopyr-
noside (X-gal; Sigma) staining were performed as pre-
iously reported (Pfeiffer et al., 1999) except that infected
ells in each 6-cm-diameter dish were subcultured into
ne or two 10-cm-diameter dishes before puromycinelection. Infection with each virus stock was performed
n parallel in three or six dishes as indicated. The num-
ers of blue and white colonies were summed for each
nfection experiment and were tabulated in Tables 1–4.
To determine lacZ inactivation rate, ET cells were
otransfected with pHIVlac and pCMVDR8.2 helper, virus
as harvested, and mATRC1/293 cells were infected,
elected in puromycin, and stained as above. The inac-
ivation rate was calculated as the ratio of white colonies
er total colonies. To determine repeat deletion rates,
HIVlaac117, pHIVlaac284, or pHIVlaac971 was used in
otransfections with helper. Where indicated, infected
ells were maintained in media supplemented with 0.2
M hydroxyurea (HU; Sigma) or 1.0 mM 39-azido-39de-
xythymidine (AZT; Sigma) until puromycin selection was
nitiated. Results reported in Tables 1 and 4 are from
xperiments in which HU or AZT treatment was started at
he end of the 1-h infection period. Experimental repeti-
ions were also performed in which HU or AZT treatment
as initiated 4 h before infection and continued through
he infection period. Under the latter condition, HU and
ZT treatment resulted in increases in lacZ inactivation
nd deletion rates that were within the range of 1.3- to
.8-fold, values which are similar to those obtained under
onditions used to generate the data reported in the
ables (data not shown).
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